| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.038 | 0.8 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.8 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.035 | 0.9 |